A 45-year-old man presents with diarrhea and abdominal pain. A biopsy reveals numerous macrophages filled with acid-fast organisms compressing lymphatic vessels. What is the most likely diagnosis?
In a patient with suspected tuberculosis, what is the most appropriate initial diagnostic test?
A patient who recently returned from a hiking trip in the Rocky Mountains presents with fever, headache, and a rash on the wrists and ankles that is progressing to the trunk. What is the most likely diagnosis, and what are the key steps for confirmation of this diagnosis?
A 30-year-old patient presents with abdominal pain and jaundice. Serological tests are positive for anti-HCV antibodies and HCV RNA. What is the next step in management?
A patient presents with severe abdominal pain and jaundice. Imaging reveals calcified cysts in the liver, and serological testing is positive for Echinococcus. What is a potential complication of this infection?
A 55-year-old male with diabetic neuropathy presents with a rapidly progressing necrotic lesion on his foot. Which organism is most likely responsible?
What is the treatment of choice for a patient with acute epiglottitis?
A patient with no significant past medical history presents with peptic ulcer disease. Testing reveals a Helicobacter pylori infection. Evaluate the recommended treatment options while considering current resistance patterns.
A patient presents with a productive cough and night sweats. Which diagnostic test would differentiate active pulmonary tuberculosis from other respiratory infections?
A healthcare worker exposed to a needlestick injury from a hepatitis B positive patient tests positive for HBsAg after 3 months. What is the next best step in management?
Explanation: ***Mycobacterium avium*** - The presence of **acid-fast organisms (AFO)** within macrophages compressing lymphatic vessels in a patient with diarrhea and abdominal pain is characteristic of **Mycobacterium avium complex (MAC)**. - MAC infection often causes widespread gastrointestinal involvement, particularly in immunocompromised individuals, leading to malabsorption and weight loss. *Giardia lamblia* - **Giardia lamblia** causes giardiasis, characterized by diarrhea, abdominal cramps, and malabsorption [2]. - However, giardia is a **flagellated protozoan** and would not appear as acid-fast organisms within macrophages [2]. *Mycobacterium tuberculosis* - While **Mycobacterium tuberculosis** is an acid-fast organism and can cause gastrointestinal disease, it typically presents with granulomas and caseous necrosis, rather than widespread macrophage infiltration with intact organisms compressing lymphatic vessels in this specific manner. - Gastrointestinal tuberculosis is less common than MAC in this presentation. *Entamoeba histolytica* - **Entamoeba histolytica** causes amebic dysentery, characterized by bloody diarrhea, and is associated with flask-shaped ulcers in the colon [1]. - It is a **protozoan parasite** and would not be identified as an acid-fast organism within macrophages [1].
Explanation: ***Chest X-ray*** - A **chest X-ray** is usually the **initial diagnostic test** for suspected active pulmonary tuberculosis (TB) to assess for lung involvement, such as **infiltrates, cavitations, or effusions** [1]. - While not definitive, it helps to **localize the disease** and can guide further diagnostic steps [1]. *Tuberculin skin test* - The **tuberculin skin test (TST)**, also known as the **Mantoux test**, primarily assesses for **latent TB infection** or previous exposure, not active disease, and cannot differentiate between the two. - A **positive TST** indicates an immune response to *Mycobacterium tuberculosis* but requires further investigation to rule out active disease. *Interferon-gamma release assay* - **Interferon-gamma release assays (IGRAs)**, like the TST, are used to diagnose **latent TB infection**, and cannot distinguish between latent and active TB [2]. - While **more specific** than TST, a positive IGRA still necessitates additional tests like a chest X-ray and sputum analysis to confirm active disease [2]. *Acid-fast bacillus (AFB) staining of sputum* - **AFB staining and microscopy** of sputum is a rapid method to identify active TB by detecting mycobacteria, providing presumptive evidence for diagnosis and guiding immediate isolation [1]. - However, it's typically performed **after an initial imaging study** like a chest X-ray suggests pulmonary involvement and before culture for definitive diagnosis [1].
Explanation: **Rocky Mountain spotted fever** - The classic triad of **fever, headache, and a centripetal rash** (starting on wrists/ankles and spreading to trunk) in a patient from an endemic area (Rocky Mountains) is highly characteristic of **Rocky Mountain spotted fever (RMSF)** [1], [2]. - Confirmation involves **serologic testing** (indirect immunofluorescence assay for IgG and IgM antibodies to *Rickettsia rickettsii*) and, in some cases, **PCR** of skin biopsy from the rash [2]. *Lyme disease* - While Lyme disease is also a tick-borne illness, its hallmark rash is **erythema migrans** (a target-like lesion), which is distinct from the described maculopapular to petechial rash of RMSF [3]. - Neurological, cardiac, and arthritic manifestations develop later in Lyme disease, and the acute presentation differs significantly. *Ehrlichiosis* - Ehrlichiosis typically presents with fever, headache, body aches, and fatigue, but a **rash is less common** (occurring in <10% of cases) and usually appears later in the course, without the characteristic centripetal progression of RMSF [3]. - Microscopic examination of peripheral blood smears may reveal **morulae within phagocytes**, a key diagnostic feature differentiating it from RMSF. *Anaplasmosis* - Anaplasmosis shares symptoms like fever, headache, and muscle aches but **rarely causes a rash** [3]. - Like ehrlichiosis, it can be diagnosed by finding **morulae within granulocytes** on a peripheral blood smear, which is not typical for RMSF [3].
Explanation: **Initiate direct-acting antivirals** - The presence of **anti-HCV antibodies** and **HCV RNA** indicates active **HCV infection**, warranting immediate antiviral treatment [1]. - **Direct-acting antivirals (DAAs)** are the current standard of care for chronic hepatitis C due to their high cure rates and favorable side effect profiles [1]. *Start interferon therapy* - **Interferon-based therapy** has largely been replaced by **DAAs** due to lower efficacy, significant side effects, and longer treatment durations for hepatitis C [1]. - It is now reserved for specific, rare circumstances where DAAs are contraindicated or unavailable. *Monitor liver enzymes* - While monitoring **liver enzymes** is part of hepatitis C management, simply observing them without active treatment for confirmed active infection would delay necessary intervention. - Monitoring is an ongoing process to assess disease progression and treatment response, not a first-line management strategy for active infection. *Perform liver biopsy* - **Liver biopsy** was historically used to stage liver fibrosis in hepatitis C, but non-invasive methods like **fibroScan** or **serum markers** are now preferred due to their safety and convenience. - It is not a necessary prerequisite for initiating antiviral therapy, especially given the clear evidence of active infection.
Explanation: ***Secondary bacterial infection of cysts*** - **Hydatid cysts** can become secondarily infected, typically after rupture or surgical manipulation, leading to an **abscess formation** within the liver. - This complication can present with features like fever, worsening abdominal pain, and an elevated **white blood cell count**, distinct from the initial presentation. *Rupture of cysts leading to anaphylactic shock* - While rupture of **hydatid cysts** can lead to **anaphylactic shock** due to the release of hydatid fluid, it is not the *most common immediate complication* or the scenario implied by abdominal pain and jaundice. - **Anaphylaxis** implies a rapid, severe systemic allergic reaction, which is a life-threatening acute event. *Portal hypertension due to cyst compression* - While large cysts can compress structures, significant **portal hypertension** due to direct compression of the portal vein by **hydatid cysts** is rare. - More commonly, portal hypertension is a complication of advanced **cirrhosis**, not typically direct cyst compression in the early stages described. *No significant complications* - **Echinococcosis** (hydatid disease) is a serious parasitic infection that almost always leads to significant morbidity if left untreated. - Cysts grow over time and inevitably cause **organ dysfunction**, pain, obstruction, or other complications.
Explanation: ***Clostridium perfringens*** - This organism is a common cause of **gas gangrene** (clostridial myonecrosis), which presents as rapidly progressing **necrotic lesions**, especially in compromised tissues like those found in diabetic neuropathy. - *C. perfringens* produces potent **toxins** that lead to rapid tissue destruction, gas formation, and systemic toxicity. *Staphylococcus aureus* - While *S. aureus* can cause severe skin and soft tissue infections, including cellulitis and abscesses, it typically does not cause the **rapidly progressing necrotic lesion** with gas production characteristic of gas gangrene. - Infections by *S. aureus* are often associated with **purulent drainage** but less with extensive tissue necrosis and gas in this context. *Streptococcus pyogenes* - *S. pyogenes* can cause **necrotizing fasciitis**, a rapidly progressing soft tissue infection, but it is typically characterized by widespread fascial necrosis with less emphasis on muscle necrosis and gas formation. - While severe, its presentation often lacks the overt **gas formation** seen with clostridial infections. *Pseudomonas aeruginosa* - *P. aeruginosa* is known to cause infections in compromised hosts, including diabetics, and can lead to **necrotic lesions** in severe cases. - However, it is more commonly associated with widespread cellulitis, osteomyelitis, or **hot tub folliculitis**, and rarely causes the fulminant, gas-producing necrosis seen with *C. perfringens*.
Explanation: ***Intravenous antibiotics*** - Acute epiglottitis is a rapidly progressive and potentially life-threatening bacterial infection, primarily affecting the **epiglottis** and surrounding structures. - **Intravenous antibiotics** are crucial for prompt treatment to prevent airway obstruction and systemic spread, as oral absorption may be delayed or insufficient. *Oral antibiotics* - **Oral antibiotics** are inappropriate for acute epiglottitis due to the acute and severe nature of the infection. - They may not achieve adequate bloodstream concentrations quickly enough to combat the rapid progression of inflammation and potential airway compromise. *Steroids* - While **corticosteroids** can help reduce inflammation, they are typically used as an adjunct to antibiotics, not as the primary treatment. - Steroids alone will not eradicate the bacterial infection responsible for epiglottitis. *Observation* - **Observation** is a dangerous approach for acute epiglottitis, as the condition can rapidly worsen and lead to **complete airway obstruction**. - Immediate medical and often airway management is necessary, not watchful waiting.
Explanation: Bismuth quadruple therapy - This regimen is highly effective, especially in regions with high clarithromycin and metronidazole resistance, making it a preferred first-line or salvage therapy. - It combines a proton pump inhibitor (PPI), bismuth subsalicylate (or subcitrate), tetracycline, and metronidazole for 10-14 days. Levofloxacin-based therapy - This is typically reserved for salvage therapy after failure of bismuth quadruple or clarithromycin triple therapy, due to increasing fluoroquinolone resistance. - Its use as a first-line option is discouraged due to the potential for selecting for resistance and its broader spectrum effects. High-dose proton pump inhibitors - While PPIs are a critical component of H. pylori eradication regimens, using them alone is insufficient to eradicate the infection. - They primarily reduce acid production to promote ulcer healing, but they lack sufficient bactericidal activity against H. pylori on their own. Clarithromycin-based triple therapy - This regimen has a declining efficacy in many regions due to rising rates of clarithromycin resistance in H. pylori [1]. - It consists of a PPI, clarithromycin, and amoxicillin (or metronidazole), and is often no longer recommended as first-line in areas with high resistance (>15-20%) [1].
Explanation: ### Sputum acid-fast bacillus stain - The **acid-fast bacillus (AFB) stain** directly identifies the presence of *Mycobacterium tuberculosis*, the pathogen responsible for tuberculosis, based on its unique cell wall properties [1]. - A positive AFB smear strongly suggests active TB, especially in a patient with **productive cough** and **night sweats** [1], [2]. *Chest X-ray* - A chest X-ray can show **pulmonary infiltrates**, **cavitations**, or **lymphadenopathy** consistent with TB, but these findings are not specific and can be seen in other respiratory infections or cancers [1]. - It aids in screening and monitoring disease progression but cannot definitively diagnose active TB or differentiate it from other infections. *Complete blood count* - A **complete blood count (CBC)** may reveal non-specific changes like **leukocytosis** or anemia of chronic disease, which are common in many infections and inflammatory conditions [3]. - It does not offer any specific diagnostic information for tuberculosis or help differentiate it from other respiratory infections. *Serum antibody test* - **Serum antibody tests** for TB have **low sensitivity and specificity**, especially for active pulmonary disease, and are not recommended for diagnosing active TB. - They primarily detect an immune response to *Mycobacterium tuberculosis* but cannot distinguish between active infection, latent infection, or past exposure reliably.
Explanation: ***Start antiviral therapy*** - A positive **HBsAg** (Hepatitis B surface antigen) at 3 months indicates **active hepatitis B infection** [1]. - Since the patient has already developed chronic infection (indicated by positive HBsAg after 3 months), **antiviral therapy** is the appropriate next step to manage the infection, prevent disease progression, and reduce transmission risk [1]. *Administer hepatitis B vaccine* - The vaccine would have been appropriate for **pre-exposure prophylaxis** or immediate post-exposure prophylaxis if the worker was not previously vaccinated and tested negative for HBsAg and HBsAb following exposure. - Administering the vaccine after the development of active infection (positive HBsAg) is **ineffective** as it is designed to prevent infection, not treat it. *Administer hepatitis B immunoglobulin* - **Hepatitis B immunoglobulin (HBIG)** provides passive immunity and is typically administered as part of **post-exposure prophylaxis (PEP)** immediately after exposure, ideally within 24 hours (and up to 7 days), especially for unvaccinated individuals, in conjunction with the vaccine [2]. - It is not indicated for treating established active or chronic hepatitis B infection, as the patient already has a positive HBsAg. *Monitor liver function tests* - Monitoring **liver function tests (LFTs)** is an important component of managing hepatitis B, both acutely and chronically, to assess liver damage and disease progression [1]. - However, simply monitoring LFTs without initiating specific treatment is **insufficient** in a patient with confirmed active hepatitis B infection. Treatment is necessary to prevent further liver damage and complications.
Principles of Antimicrobial Therapy
Practice Questions
Fever of Unknown Origin
Practice Questions
HIV/AIDS and Related Infections
Practice Questions
Tuberculosis and Mycobacterial Diseases
Practice Questions
Tropical and Parasitic Infections
Practice Questions
Viral Infections (Hepatitis, Herpes, etc.)
Practice Questions
Healthcare-Associated Infections
Practice Questions
Fungal Infections
Practice Questions
Sepsis and Septic Shock
Practice Questions
Infection in Immunocompromised Hosts
Practice Questions
Emerging and Re-emerging Infections
Practice Questions
Antimicrobial Resistance
Practice Questions
Vaccination Principles
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free